-
Document de presse | 2013.02.06
Treatment of Cutaneous Leishmaniasis: Study of Phase III Shows Antibiotic Cream Has High Cure Rate, Few Side Effects
An international research partnership from Tunisia, France and the United States has demonstrated a high cure rate and remarkably few side effects in treating patients with cutaneous leishmaniasis (CL) with an antibiotic cream. CL is a parasitic disease that causes disfiguring lesions and affects 1.5 million people worldwide annually, including the socio-economically disadvantaged in the...
-
Document de presse | 2008.10.05
Nobel Prize in Medicine 2008 awarded to Professors Françoise Barré-Sinoussi and Luc Montagnier
The Nobel Prize in Medicine 2008 has been awarded to Professors Françoise Barré-Sinoussi and Luc Montagnier for their discovery of the human immunodeficiency (AIDS) virus in 1983 at the Institut Pasteur, and to Prof. Harald zur Hausen for his discovery of the human papillomavirus, which is responsible for cervical cancer. Press releaseParis, october 6, 2008 “Twenty five...
-
Document de presse | 2013.11.04
Two European programs reinforce the fight against emerging diseases
The 31 partners involved in the two major European research programs PREDEMICS and ANTIGONE are to meet for a joint seminar at the Institut Pasteur on November 6th. These two programs will respectively receive €11.7 million and €12 million funding of the European Union over five years to study the emergence mechanisms of infectious diseases in order to strengthen existing treatment and...
-
Document de presse | 2016.11.04
Malaria – Discovery of a molecular marker associated with piperaquine resistance in parasites
A collaborative project conducted by scientists from the Institut Pasteur in Cambodia, the Institut Pasteur in Paris, the Institut Cochin, the Laboratory of Applied Mathematics at Paris Descartes University, Columbia University (New York, USA) and the National Malaria Control Program in Cambodia has identified a molecular marker able to detect Plasmodium falciparum malaria parasites resistant to...
-
Document de presse | 2019.01.24
The new Institut Pasteur strategic plan for 2019-2023
After taking office as President of the Institut Pasteur in January 2018, Professor Stewart Cole embarked on the development of a new strategic plan for the Institut Pasteur for the period 2019-2023. On December 21, 2018, the Board of Directors unanimously adopted this ambitious yet realistic action plan for the next five years.Three priority scientific areas have been identified: • emerging...
-
News | 2020.02.18
The Chinese Ambassador to France visits the Institut Pasteur
On Friday February 14, 2020, Stewart Cole, President of the Institut Pasteur, played host to His Excellency Mr Lu Shaye, Chinese Ambassador to France, who was visiting the Institut Pasteur to show support both personally and on behalf of his country for the Institut Pasteur’s efforts in response to the novel coronavirus outbreak. The visit provided an opportunity to introduce the ambassador and...
-
Document de presse | 2020.07.27
Malaria: parasite resistance to artemisinin derivatives now affecting Africa
Resistance to artemisinin, the main component of the current antimalarial treatments recommended by WHO, is already widespread in South-East Asia, but it had not previously been described in Africa. Scientists from the Institut Pasteur, in collaboration with the National Malaria Control Program in Rwanda (Rwanda Biomedical Center), the World Health Organization (WHO), Cochin Hospital and Columbia...
-
Document de presse | 2022.07.13
Light shed on SARS-CoV-2 replication in bat cells
Bats are reservoir species for numerous viruses including coronaviruses. Given that they do not appear to be affected by diseases transmitted by these viruses, there is potential benefit in understanding how their immune system regulates infection. Scientists at the Institut Pasteur and the CNRS studied SARS-CoV-2 replication in bat cells, which involved using real-time imaging techniques for the...
-
Document de presse | 2023.01.25
Discovery of a circovirus involved in human hepatitis
Scientists from the Institut Pasteur, Necker-Enfants Malades Hospital (AP-HP), Inserm in the Imagine Institute, Université Paris Cité and the Alfort National Veterinary School (EnvA) have identified a previously unknown species of circovirus, provisionally named human circovirus 1 (HCirV-1). Circoviruses are a family of small, highly resistant DNA viruses that were initially identified in 1974 in...
-
Portrait | 2023.10.02
Javier Pizarro-Cerda : science, plague and rock'n roll!
Javier Pizarro-Cerda's upbringing gave him curiosity, an interest in biology and science, as well as a lifelong passion for music! After his studies in Costa Rica, he came to Europe to become a scientist.Today at the Institut Pasteur in Paris, his research on plague and other Yersinia infections follows on from the work of his predecessors and also explores the history of deadly epidemics of the...